Swanhill Capital

1DOC3 is an e-health platform that connects Spanish-speaking individuals, totaling approximately 490 million, with licensed medical professionals. The platform allows users to seek personalized answers to their health-related inquiries through various channels, including web, mobile applications, SMS, and USSD, ensuring accessibility even for those without internet access. This service enables doctors to enhance their online reputation and attract new patients while contributing to a comprehensive database of curated health-related questions and answers in Spanish. By facilitating direct communication between users and healthcare providers, 1DOC3 aims to address health concerns and promote overall well-being in the communities it serves.

Cohero Health, Inc. is a digital respiratory health company that focuses on improving the management of asthma and chronic obstructive pulmonary disease (COPD). Founded in 2012 and based in New York, the company offers a proprietary connected health platform that combines sensor-based technology with a mobile application. This platform includes the BreatheSmart app, which provides customized medication reminders, records inhaler usage, and tracks lung function, symptoms, and environmental conditions over time. Cohero Health's product suite features mSpirometer lung function sensors and HeroTracker, a Bluetooth-enabled inhaler tracker that monitors both control and rescue medications. Additionally, BreatheSmart Connect serves as a Software-as-a-Service solution for remote patient monitoring and communication, enhancing coordination between patients and healthcare providers. By utilizing these tools, Cohero Health aims to improve medication adherence and overall health outcomes for individuals with respiratory conditions.